CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: The MultiEthnic Study of Atherosclerosis

Coronary Artery Disease

Volumn 26, Issue 8, 2015, Pages 678-685

  Darabian, Sirous ^a   Luo, Yanting ^a   Homat, Arman ^f   Khosraviani, Khashayar ^c   Wong, Nathan ^b   Zeb, Irfan ^d   Nasir, Khurram ^e   Budof, Matthew J ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d BRONX LEBANON HOSPITAL CENTER   (United States)

^e MIAMI CANCER INSTITUTE   (United States)

^f Department of Internal Medicine   (Canada)

Author keywords

Angiotensin converting enzyme inhibitors; Atherosclerosis; Coronary artery calcification; Coronary artery calcium score; Multi ethnic

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; ELECTRON BEAM TOMOGRAPHY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RISK REDUCTION; VERY ELDERLY; ANGINA PECTORIS; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; HEART STROKE VOLUME; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; UNITED STATES; VASCULAR CALCIFICATION; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY VESSELS; ETHNIC GROUPS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; VASCULAR CALCIFICATION;

EID: 84947127776     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000303     Document Type: Article

References (14)

1. Bian B, Kelton CM, Guo JJ, Wigle PR. ACE inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008. J Manag Care Pharm 2010; 16:671-679.
2. The SOLVD investigators. Effect of Enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
3. Pfeffer MA, Braunwald E, Moye LA, et al. on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival And Ventricular Enlargement (SAVE) trial. N Engl J Med 1992; 327:669-677.
4. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145-153.
5. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.; Lancet 1999; 353:611-616.
6. Donnelly R, Manning G. Angiotensin-converting enzyme inhibitors and coronary heart disease prevention. JRAAS 2007; 8:13-22.
7. van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158, 998 patients. Eur Heart J 2012; 33:2088-2097.
8. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2009; 158:554-561.
9. Blaha MJ, Blumenthal RS, Budoff MJ, Nasir K. Understanding the utility of zero coronary calcium as a prognostic test: a Bayesian approach. Circ Cardiovasc Qual Outcomes 2011; 4:253-256.
10. Shareghi S, Ahmadi N, Young E, Gopal A, Liu ST, Budoff MJ. Prognostic significance of zero coronary calcium scores on cardiac computed tomography. J Cardiovasc Comput Tomogr 2007; 1:155-159.
11. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007; 50:319-326.
12. Pundziute G, Schuijf JD, Jukema JW, Decramer I, Sarno G, Vanhoenacker PK, et al. Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 2008; 29:2373-2381.
13. Kitagawa T, Yamamoto H, Horiguchi J, Ohhashi N, Tadehara F, Shokawa T, et al. Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging 2009; 2:153-160.
14. Budoff MJ, Nasir K, Kinney GL, Hokanson JE, Barr RG, Steiner R, et al. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr 2011; 5:113-118.